Streetbeat News

Revenues

DUOL

Duolingo shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:13 am

HIMX

Himax Technologies reported Q2 2024 GAAP EPADS of $0.17, beating the estimate of $0.12. Sales were $239.622 million, surpassing the expected $229.340 million.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:13 am

KVYO

Klaviyo shares are trading higher after the company reported better-than-expected Q2 financial results and issued FY24 and Q3 revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:11 am

BROS

Dutch Bros shares are trading lower following FY24 revenue guidance slightly below estimates.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:11 am

LFST

LifeStance Health has raised its full-year 2024 revenue guidance to $1.2 billion-$1.242 billion, with improved Center Margin and Adjusted EBITDA. For Q3 2024, the company expects revenue of $290 million-$310 million, which is in line with estimates.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:11 am

LNG

Cheniere Energy (AMEX:LNG) reported Q2 2024 earnings per share (EPS) of $3.84, significantly beating the analyst estimate of $1.69. However, sales of $3.251 billion missed the $3.518 billion estimate. Both EPS and sales figures are down compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:10 am

LFST

LifeStance Health has raised its 2024 revenue guidance to $1.2B-$1.242B, up from the prior $1.19B-$1.24B, and expects adjusted EBITDA of $90M-$100M. The company also anticipates positive free cash flow for the full year. For Q3 2024, LifeStance projects revenue of $290M-$310M and adjusted EBITDA of $15M-$21M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:10 am

FROG

JFrog shares are trading lower after the company reported worse-than-expected Q2 revenue results and issued FY24 and Q3 guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:10 am

GDRX

GoodRx has provided its Q3 2024 revenue outlook, projecting $193M-$197M, which is below the $202.4M estimate. The company expects a year-over-year revenue increase of 7%-9% and an adjusted EBITDA margin of approximately 32%.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:08 am

WBD

Warner Bros. Discovery shares are trading lower following Q2 financial results, which included a decline in advertising revenue.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:07 am